A New Era in Vision Restoration: BCI Technology Enters the EU Market

A retinal implant developed by US-based startup Science Corp. has recently secured regulatory approval for sale within the European Union. Designed to restore partial vision in patients with geographic atrophy (an advanced form of dry age-related macular degeneration), this milestone signals a pivotal shift for brain-computer interface technology from research labs to broader clinical practice.

How It Works: A Symphony of Light and Electricity

At the heart of the system is an ultra-thin subretinal implant called PRIMA. Patients wear a pair of custom glasses that enable its function through an elegant process:

  • Wireless Power and Data: The glasses project a beam of near-infrared light onto the implant.
  • Photovoltaic Conversion: Microscale solar cells on the implant convert the received light into gentle electrical pulses.
  • Neuronal Stimulation: These pulses stimulate the remaining healthy cells in the retina, generating visual perceptions in the brain.

The system also incorporates a digital zoom feature, assisting patients with tasks like reading text, thereby significantly improving practical usability.

More Than a Therapy: A Commercial Milestone for BCI

The significance of this approval extends beyond its medical application. It represents the first time a US BCI company has introduced a device to a large-scale consumer market, successfully transitioning from proof-of-concept to a marketable product. The company's long-term roadmap is even more ambitious—aiming to develop implants that interface directly with the brain. The success of this retinal chip provides invaluable regulatory experience, manufacturing know-how, and clinical data, paving the way for future, more complex neural interface technologies.

This development offers a new treatment avenue for millions worldwide affected by degenerative vision loss. It demonstrates that repairing functional deficits through direct "dialogue" between sophisticated electronics and the human nervous system is steadily moving from science fiction to tangible reality.